Open-source institutional guideline recommendations during the COVID-19 pandemic

CONCLUSION: Overall, the analysis revealed variability in treatment or supplemental pharmacologic therapy for the management of COVID-19.PMID:34279573 | DOI:10.1093/ajhp/zxaa252

Source: American Journal of Health-System Pharmacy : AJHP - July 19, 2021 Category: Drugs & Pharmacology Authors: Curtis D Collins Jean Huang Brian A Potoski Source Type: research